Clinical Trials List
Protocol NumberB2611003
Completed
2011-07-01 - 2012-12-31
Phase II
Terminated3
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 林時逸 Division of Endocrinology
- JUN-SING WANG Division of Endocrinology
- I-TE LEE Division of Endocrinology
- 蔡易婷 Division of Endocrinology
- 傅家保 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 郭銘俊 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yu-Yao Huang Division of Endocrinology
- 張宏猷 Division of Endocrinology
- 劉妙真 Division of Endocrinology
- Jhao-Shan Hwang Division of Endocrinology
- 李麒麟 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
288 participants
